C12N 2730/10151
Methods of production or purification of viral material
C12N2730/10151 (Methods of production or purification of viral material) appears on 23 US grants and 44 published applications in this corpus.
Search patents in C12N- Granted patents
- 23
- Published applications
- 44
- Assignees
- 36
- Inventors
- 130
- Latest grant
- 2 Apr 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 4 |
| 2011 | 1 | 2 |
| 2012 | 1 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 4 |
| 2015 | 0 | 4 |
| 2016 | 3 | 6 |
| 2017 | 1 | 4 |
| 2018 | 3 | 2 |
| 2019 | 3 | 1 |
| 2020 | 3 | 1 |
| 2021 | 1 | 3 |
| 2022 | 0 | 2 |
| 2023 | 0 | 0 |
| 2024 | 1 | 3 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tetravalent dengue vaccine2 Apr 2024US 11,945,842 B2International Centre for Genetic Engineering and Biotechnology
- Method for separating virus-like particles from a cell suspension6 Jul 2021US 11,053,478 B2Artes Biotechnology GmbH
- Method of obtaining a polyepitopic protein and polyepitopic DNA vector29 Dec 2020US 10,874,735 B2Bioventures Institute Sp. Z O. O.
- Tetravalent dengue vaccine27 Oct 2020US 10,815,280 B2International Centre for Genetic Engineering and Biotechnology
- Development of HBV-and/or HDV-susceptible cells, cell lines and non-human animals14 Apr 2020US 10,618,947 B2Ruprecht-Karls-UniversitäT Heidelberg
- Use of virus-like particles in vaccination26 Feb 2026US 2026/0053900 A1The Chinese University of Hong Kong
- Multi-antigen therapeutic vaccines to treat or prevent chronic hepatitis b virus infection10 Oct 2024US 2024/0335531 A1Carogen Corporation
- Vaccine compositions and methods of use thereof16 May 2024US 2024/0156948 A1Excepgen Inc.
- Virus-like particles and methods of production thereof21 Mar 2024US 2024/0093159 A1University of Dundee
- Method for Producing Virus-Infected Cell Line and Animal Model14 Apr 2022US 2022/0112515 A1Industry-Academic Cooperation Foundation, Yonsei University
Most cited
By later US patents
- Method of removal of hepatitis virus29US 4,168,300 AAB Kabi · 1979
- Method for purifying viral nucleic acids17US 5,958,677 ANew York Blood Center, Inc. · 1999
- Process for purifying particles of biological origin, particularly the surface antigen of the virus of hepatitis B (AgHBs)4US 4,335,214 AInstitut Pasteur · 1982
- Method for detecting viral compounds using a .beta.2'-glycoprotein I4US 5,650,269 A1997
- Scalable process for protein purification4US 7,888,098 B2Cytos Biotechnology AG · 2011